Prolexys Pharmaceuticals Inc is categorized under Scientific Research Agency in Salt Lake City, UT and active since 2001.
Prolexys Pharmaceuticals Inc was established in 2001, and today employs 1 to 4, earning $50.000.000 to $99.999.999 per year. This is a Scientific Research Agency business, which does work in the B2B market, and is classified as a Scientific Research Agency, under code number 4242101 by the NAICS.
If you are seeking more information, feel free to contact Tracy Erkkila, Cio-Cto at the company’s single location by writing to 1035 North Flyer Way, Salt Lake City, Utah UT 84116 or by phoning (801) 303-1700. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Prolexys Pharmaceuticals Inc |
| Contact Person: | Tracy Erkkila, Cio-Cto |
| Address: | 1035 North Flyer Way, Salt Lake City, Utah 84116 |
| Phone Number: | (801) 303-1700 |
| Annual Revenue (USD): | $50.000.000 to $99.999.999 |
| Founded: | 2001 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Scientific Research Agency |
| SIC Code: | 8733 |
| NAICS Code: | 4242101 |
| Share This Business: |
Prolexys Pharmaceuticals Inc was started in 2001 to provide professional Scientific Research Agency under the SIC code 8733 and NAICS code 4242101. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $50.000.000 to $99.999.999 per annum.
Feel free to contact Tracy Erkkila, Cio-Cto for inquiries that concern Prolexys Pharmaceuticals Inc by calling the company number (801) 303-1700, as your correspondence is most welcome. Additionally, the physical location of the single location of Prolexys Pharmaceuticals Inc can be found at the coordinates 40.77429,-111.96559 as well as the street address 1035 North Flyer Way in Salt Lake City, Utah 84116.
For its online presence, you may visit Prolexys Pharmaceuticals Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.